Category

Clinical Trials

Macchiarini on trial in Sweden

April 28, 2022

Paolo Macchiarini who made headlines …

Bavarian Nordic Research

Bavarian Nordic initiates global Phase 3 trial

April 20, 2022

Bavarian Nordic has announced the …

Genmab announces phase 1/2 trial results

April 20, 2022

Genmab and AbbVie have announced …

Johan Luthman

New results from Lundbeck’s vortioxetine trial

April 20, 2022

Lundbeck recently completed a global …

Karl Bergman and Francesco Gatto

Elypta launches multi-cancer early detection study

April 8, 2022

Elypta has announced the launch …

Janet Hoogstraate and Lena Hallengren

Sweden’s first COVID-19 vaccine facility inaugurated

April 7, 2022

Sweden’s Minister of Health and …

TILT Biotherapeutics reports Phase I results

March 31, 2022

TILT Biotherapeutics has announced positive …

The new EU Clinical Trial Regulation: Key considerations

March 29, 2022

LINK Medical is currently preparing …

Alexandra Ekman Ryding

Atrogi receives regulatory approval from German health authority

March 29, 2022

Atrogi has received approval from …

Carl-Johan Dalsgaard

Vicore strengthens its rare lung disease pipeline

March 28, 2022

Vicore Pharma Holding has announced …

Susan Galbraith

AstraZeneca’s CALLA trial did not achieve statistical significance for the primary endpoint

March 28, 2022

The CALLA Phase III trial …

First expansion cohort in IMPRESS-Norway

March 28, 2022

The Regional Health Authorities in …

Johan Aschan

First patient treated in XNK Therapeutics study

March 23, 2022

XNK Therapeutics has announced that …

Kim Kjøller

Union Therapeutics enrolls first patient in Phase 2b study

March 16, 2022

UNION therapeutics has announced that …

New results from AstraZeneca’s MELODY trial

March 7, 2022

Detailed results from the MELODY …

Göran Forsberg Photo Håkan Sandbring

Cantargia reports encouraging results

March 2, 2022

Cantargia has reported new encouraging …

1
2
3
4
···
42